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Scaffolds are biomaterials serve as substrates for cell attachment and provide 
microenvironments for cell growth. Though they were initially designed for in vitro tissue 
growing applications, they are gaining increasing importance in cell therapy, where they 
serve as delivery vehicles of cells to overcome the low cell retention and survival resulted 
from delivering cells alone. An ideal scaffold for cell therapy should be optimized in 
multiple properties, including mechanical property, biocompatibility and 3D structures. 
However, traditional scaffolds were limited by their materials and fabrication techniques that 
they can hardly optimize multiple properties at once. Therefore, in this dissertation
①
 three 
novel scaffolds with integrated properties were represented and their applications in cell 
delivery were demonstrated.  
Polyester microfibers and hydrogels are two most studied type of scaffolds. Polyester 
microfibers are hydrophobic. They have good mechanical property and fibrous porous 
structure. Hydrogels are water absorbable and usually have good compatibility. However, 
their application is often limited by weak mechanical strength. In the first part of this 
dissertation, a surface RAFT polymerization technique was developed and for the first time 
achieved nano-thin PEG hydrogel coating on PCL micro-fiber surface. This composite 
scaffold showed good macro-mechanical property and fibrous, porous structure like 
microfibers. Meanwhile, after integration of hydrogel, the hydrophobic scaffold became 
water-absorbable like hydrogels and showed improved biocompatibility. The method applied 
in this study could be transformed to other polyester scaffolds as well to make integrated 
materials.  






apoptosis caused by clumping. Therefore, scaffolds for delivering microtissues should have 
the ability to regulate their spatial distribution. However, traditional scaffolds are usually 
designed to regulate cell microenvironments in nano to micro scale, such as electrospun 
fibers and hydrogels, and lack the ability of spatial regulation in higher magnitudes. 
Therefore, in the second part of this dissertation, a novel method for microtissue 
transplantation was demonstrated. Microwell patterns were introduced on surface of 
electrospun fibers through microfabrication technique. This microwell patterned electrospun 
fibers regulated the spatial distribution of MSC spheroids and maintained their improved 
paracrine function. MSC spheroids loaded microwell patterned scaffolds were further 
transplanted in mice with hind limb ischemia. Results showed that the microwell patterned 
scaffolds increased MSCs’ retention and survival and improved the vascularization of 
ischemic tissues. 
The interaction between host tissue and transplanted cells can be controlled by careful 
design of the scaffold structure and pore size. In the third part of this dissertation, a pore size 
controllable spherical hollow scaffold was designed for cell transplantation. Comparing with 
hydrogel beads, this novel spherical scaffold has a double layer spherical structure, better 
mechanical property and a wider control in pore size. MSCs can be injected inside the 
hollow core of scaffold for transplantation. The scaffold could improve MSCs’ paracrine 








CHAPTER 1. INTRODUCTION 
1.1 Aims  
Scaffolds are the biomaterials used in tissue engineering, where they function as 
substrates for cell attachment and provide biochemical and physical cues to establish 
microenvironments to support cell growth, differentiation and other functions[1-3]. With the 
rapid development in stem cell technology, besides the initial purpose of growing tissues, 
scaffolds have found new applications in cell therapy, where they serve as platforms for cell 
delivery with focusing on improving cell retention and survival[4, 5].  
The in vivo performance of scaffold is dependent on various characteristics including 
mechanical properties, biocompatibility and micro, macro-architectures[6]. However, 
traditional scaffolds often have limited optimization of different properties, which limited 
their function and final application. Therefore, to fulfill the diverse requirements of scaffolds, 
integrative designs must be adopted.  
The central hypothesis of this dissertation is that the judicious designs is able to 
develop scaffolds with integrated properties and functions, and the scaffolds with integrated 
properties could benefit cell retention and survival in cell transplantation. The central 
hypothesis was studied following three specific aims. 
1.1.1 Specific aim 1 
Development of scaffolds with integration of hydrogel on surface of polyester microfiber 
Hydrophobic plastic polymers, which are mechanically tough and stable, can be 






polymer-based materials handy to maneuver and useful in a wide range of medical devices [7-
9]. Hydrogels made of hydrophilic networks are capable of absorbing water and the hydrated 
systems often show superior biocompatibility in comparison to hydrophobic polymers by 
reducing the protein adsorption and displaying tissue-like elasticity [10]. However, hydrogels 
often exhibit relatively weak mechanical strength, and the materials may deform easily under 
pressured or water-vaporization conditions. I hypothesized that with integration of hydrogels 
on polyester microfiber surface could take the advantage of both scaffolds and overcome 
their limits. Surface RAFT polymerization technique was used to coat hydrogel on PCL 
electrospun fibers and characterized the chemical, mechanical, in vitro cell attachment and in 
vivo biocompatibility of the scaffold with hybrid structure. 
1.1.2 Specific aim 2 
Development of scaffolds with microwell patterning on electrospun fibers for MSC spheroids 
transplantation 
To better mimic the natural ECM structure, classic scaffolds such as electrospun fibers 
are designed to have architectures in micro-scale. Such micro-architectures have the ability 
to regulate cells on cellular/subcellular level by modulating the local biochemical and 
physical microenvironment. With the rapid advancement in stem cell technologies, different 
microscale tissues or organoids have been produced through scalable processes [11, 12]. These 
microtissues often exhibit superior therapeutic functions to single cells. To successfully 
transplant those microtissues, scaffolds should have the ability to not only control local 
microenvironments on cellular/subcellular level, but also manipulate their spatial distribution 
on a larger scale (hundreds of microns to a few millimeters) to ensure efficient 






clumping. In this specific aim, I hypothesized that the introduction of microwell patterns on 
electrospun fibers could control the spatial distribution of MSC spheroids and benefit MSC 
spheroids transplantation in vivo. Microwell patterned electrospun fibers were fabricated and 
the in vivo performance was characterized by transplanting MSC spheroids loaded scaffolds 
in mice model of hind limb ischemia. 
1.1.3 Specific aim 3 
Development of hollow spherical scaffolds with controllable pore size for MSC 
transplantation  
Cell adhesion and migration, tissue ingrowth and vascularization are strongly related 
to pore size. In this specific aim, I hypothesized that the pore size controllable hollow 
spherical scaffold could have the ability to control over the cell retention and survival after 
cell transplantation. The hollow spherical scaffolds were fabricated through phase separation 
technique. The mechanical property, mass transfer efficiency and in vitro cell function of 
scaffolds were characterized with different pore size. The in vivo performance of scaffolds 
was further investigated in MSC transplantation. 
1.2 Backgrounds 
1.2.1 Tissue scaffolds and their properties 
Many tissues such as myocardium, nerves, bones and cartilage can hardly regenerate, 
which made damages to these tissues irreversible. One possible solution is tissue/organ 
transplantation. However, the donors are too few to meet the demand. Tissue engineering is 
an alternative method to treat damage to those tissues. The idea of tissue engineering is to 






example, Keiji et al. seeded vascular SMCs on PCLA patches and found that the cell-seeded 
grafts could improve LV function of rats after myocardial infarction [13]. The materials used 
in tissue engineering are called scaffolds, which serve as the substrates for cell attachment 
and provide specific environments for tissue growth. Currently two types of scaffolds: 
premade porous scaffold Figure 1.1 (A-C) and in situ formed hydrogels Figure 1.1 (D) are 
most applied. With the rapid development in stem cell technology, besides the initial purpose 
of growing tissues, scaffolds have found new applications in cell therapy, where they serve 
as platforms for cell delivery with focusing on improving cell retention and survival, as 
demonstrated later in this chapter. 
The in vivo capacity of scaffold in determined by multiple properties and can be 
classified into mechanical property, biocompatibility and geometric property. During 
implantation, scaffolds often have to encounter compressive forces while handling from 
tweezers or shear stress from injections. After implantation, scaffolds also need to resist 
compressive and hydro-static forces in host tissue. Therefore, the scaffold should possess 
sufficient mechanical property to remain integrity during and after transplantation. It is 
generally accepted that an ideal scaffold should have similar mechanical property as the 
tissue to be regenerated. In addition, mechanical property also affects the processablity of 
scaffold. Materials with too strong or too weak mechanical ability can be hardly fabricated 








Figure 3.1 Scaffold fabricated by (A) gas foaming, (B) phase separation, (C) 
electrospinning and (D) in situ formed hydrogels (Qiu Li Loh et al. Tissue Engineering 
Part B: Reviews. 2013, 19(6): 485-502, Landázuri, Natalia, et al Journal of tissue 







directly as well. For example, studies showed that MSC differentiated into different lineage 
on substrate with different stiffness [14].  
The basic requirement in biocompatibility is that the material should not be cytotoxic. 
The scaffold and its degradation product should not harm the transplanted cells and host 
tissue. In addition, good biocompatibility also requires a minimal triggering of foreign body 
reaction. Otherwise the scaffold will be surrounded with a thick layer of fibrotic tissue and 
the transplanted cells will start necrosis and apoptosis due to hypoxia. The factors that 
determines scaffold’s biocompatibility includes materials’ chemical composition, structure, 
and their morphology and also their sterilization conditions. Wettability and hydrophilicity 
are often related to biocompatibility. It is generally considered that materials with higher 
water content are more biocompatible, such as hydrogels. 
Figure 1.2 Cell response is dependent on multiple properties of scaffolds. (Joyce et al. , 






Geometric properties include the scaffolds’ shape, topology, porosity, pore size and 
interconnectivity. Scaffolds are typically porous structured. The high porosity offers a high 
surface/volume ratio which facilitates cell attachment. The interconnected network of pores 
is essential for the diffusion of nutrient and cellular waste. Pore size controls the 
permeability of molecules as well as cells. Relatively, larger pore size (>1 μm) is designed to 
facilitate cell migration (in and out) and blood vessel ingrowth and smaller pore size (<1μm) 
is usually designed to prevent cell migration, which is often used in immunoisolation devices. 
Topology has been shown to affect cell function. For example, previous studies in our lab 
has also proved that surface nanotopography could affect the biocompatibility of scaffold 
that electrospun nanofibers induced only minimal FBRs with indiscernible activation of 
macrophage cells compared to microfibrous membranes [15]. On a larger scale, as described 
later in this dissertation, micropatterning on hundreds of microns could facilitated the spatial 
distribution of microtissues and promote vascularization. On macro-scale level (>a few 
millimeters), scaffolds can be made into membrane shaped for convenient cell migration or 
made into capsules to limit host-transplants interaction. 
1.2.2 Electrospinning 
Electrospinning is a simple and versatile method for fabrication of continuous fibers 
with nano- to micrometer range diameters and has gained increasing attention in the past 
decade. A wide range of polymers can be applied for electrospinning including synthetic 
polymers such as PCL and PLGA[16] and natural derived polymers such as collagens[17]. A 
typical electrospinning set up is illustrated in Figure 1.2 A. It usually consists of three major 
components: a high-voltage supply, a syringe pump, and a collector. When a high voltage is 






electrostatic force exceeds the surface tension, the polymer droplet will erupt from droplet 
and form continuous stream. During the stream move toward the collector, the solvent 
evaporates and the stream is elongated and becomes thinner by a whipping process[18]. 
Usually the fibers collected are random oriented as shown in Figure 1.2 B. 
 
 
Figure 1.3 (A) Common electrospinning set up (B) Random aligned electrospun PCL 
fibers (C) Decellularized porcine aortic valve (Ye X, et al. PLoS ONE, 2013) 
Electrospun fibers have wide biomedical applications, not only due to the versatile 
materials applied, but also because their fibrous architecture resembles the structure of native 
ECM. ECM is a collection of polysaccharides such as hyaluronic acid and proteins such as 






strong effect in regulating cell adhesion, migration and differentiation [19]. As showed in 
Figure 1.2C, native ECM has fibrous structures with fiber diameter ranging from 
nanometers to micrometers, very similar to electrospun fibers. One principle of tissue 
engineering is to mimic natural cells’ microenvironment as close as possible. Therefore, the 
resemblance of electrospun fibers to native ECM made them good candidates for developing 
desired stem cell niche.  In addition, the high surface area could promote cell adhesion and 
migration, and the high porosity could also facilitate nutrient transfer[19,20]. 
 Electrospun fibers have been widely applied as tissue engineering scaffolds. For 
example, Peter I. Lelkes et al. fabricated anisotropic scaffolds with electrospinning of 
polycarbonate-urethane and PLGA. They found the scaffolds could support adhesion and 
proliferation of cardiac myoblasts and exhibited mechanical properties comparable to those 
of a human heart[21]. H. Yoshimoto et al. cultured mesenchymal stem cells with osteogenic 
supplements under dynamic culture conditions and found the cell-polymer constructs were 
covered with cell multilayers and mineralization and type I collagen were observed at 4 
weeks, suggesting that electrospun PCL is a potential candidate scaffold for bone tissue 
engineering[22]. Changjian Liu et al. developed a tissue-engineered vascular graft with 
electrospinning a hybrid of chitosan/poly(ɛ-caprolactone). They seeded endothelial cells on 
scaffold and implanted in vivo. After 3 months, they observed a regeneration of endothelium, 
and the presence of collagen and elastin, indicating the potential of electrospun fibers in 
vascular graft applications[23]. 
1.2.3 Electrospun fiber and hydrogel composite scaffolds 
Electrospun fibers and hydrogels are two of the most studied types of materials in the 






provide desired cell niche for tissue engineering and cell delivery applications [24]. 
Electrospun fibers, as have been described in last section, usually have good mechanical 
strength and large surface area. Hydrogels usually have high water content and superior 
biocompatibility. However, they are usually mechanically weak. Therefore, the integration 
Electrospun fibers and hydrogels are two of the most studied types of materials in the field of 
tissue engineering. They can both replicate the components of native ECM and provide 
desired cell niche for tissue engineering and cell delivery applications [25]. Electrospun fibers, 
as have been described in last section, usually have good mechanical strength and large 
surface area. Hydrogels usually have high water content and superior biocompatibility. 
However, they are usually mechanically weak. Therefore, the integration of electrospun 
fibers and hydrogel may offer potential to develop superior scaffolds, with a combination of 
advantages of both materials and overcome their weakness. Meanwhile, the native ECM 
itself is composed of fibrous proteins and gel like glycosaminoglycans. The integration of 








Figure 1.4 Electrospun fiber and hydrogel composite scaffolds. (A, C) Schematic 
demonstrating encapsulating electrospun fibers in hydrogels and co-
electrospinning/electrospraying of fibers and gels (B, D) SEM images of composite 
scaffolds fabricated by encapsulating electrospun fibers in hydrogels and co-
electrospinning/electrospraying of fibers and gels. (A, B: McMahon et al. Tissue 
Engineering Part C: Methods, 2011; C: Bosworth et al. Nanomedicine: Nanotechnology, 
Biology and Medicine, 2013; D: Y. Hong et al. Biomaterials, 2011) 
There have been some studies investigating electrospun fibers and hydrogels 
composite scaffolds. Current approaches can be divided into two categories: encapsulating 
electrospun fibers in hydrogels [26-28]; 2) co-electrospinning/electrospraying of fibers and gels 
[29,30] (Figure 1.4 A, D). In first approach, electrospun fibers are immersed in hydrogel 






fabricated cells seeded hydrogel–electrospun mesh composites for coronary artery bypass 
grafts. In this study, smooth muscle cells were seeded on electrospun meshes [31]. The cells 
seeded mesh was wrapped around a tube and incubated in fibrinogen-thrombin solution, 
followed by immersing in PEGDA solution and polymerization by UV light. They described 
that the mechanical properties of this composite scaffold mimic those of coronary artery 
vessels, which electrospun fibers alone cannot achieve. In the co-
electrospinning/elecrospraying method, fiber’s polymer solution and gel precursor solution 
was electrospun/elecrosprayed simultaneous on one collector. For example, Ekaputra et al. 
developed a composite scaffold by electrospinning a mixed solution of poly(ε-caprolactone) 
and collagen, whilst coinciding with the electrospraying of a hydrogel solution based on 
glycosaminoglycans on a rotating medrel. They found the pore size of composite material 
increased significantly that allows cells to infiltrate, where for scaffold with electrospinning 
alone cells only stayed on surface [32]. In both approaches, the distribution of hydrogels in 
composite materials is inhomogeneous (Figure 1.4 B, D). The composite often showed 
laminated structure, with hydrogels filling between each layer. The pores of electrospun 
fibers were also filled with hydrogels randomly.  
1.2.4 Micropatterning 
The process of fabricating regular micro-scale patterns on surface of material is called 
micropatterning. Micropatterning technique can easily control the cell and tissue 
morphology and further affect their function. Different patterns have been designed for 
different purposes. For example, Mirjam et al. seed cells on the microwell patterned PDMS, 
phalloidin staining of actin stress fibers showed that the cytoskeleton of cells in microwells 






micropatterned hydrogel through a micromolding technique. His team seeded HepG2 
microtissues in the micropatterned hydrogel and found that the tissues’ morphology, 
distribution and size are dependent on the shape of the molds, but their viability and cytokine 
secretion are dependent on the seeded cell number [34]. McDevitt’ lab used commercialized 
Aggrewell TM to produce MSC aggregates. His team found that comparing with single cells, 
MSC aggregates have more homogenous differentiation [35]. In 2007 and 2010, researchers 
from University of Korea and MIT cultured ESCs on microwell patterned substrate and 
achieved embryoid body with homogenous size and shape. They discovered gene 
expressions of three germ layers from gastrula and found that the size of embryoid body 
could affect the differentiation into myocardium and nerve. These experiments proved the 
micropatterning technique’s potential in controlling stem cell differentiation and application 
in regenerative medicine. In addition, the 3-D micropatterning offered a way to control the 
spatial distribution and sufficient nutrient supply of cells in high density, which are greatly 








Figure 1.5 Examples of micropatterning technique (left: Jiang LY et al. Sci. China Life 






1.2.5 Mesenchymal stem cell transplantation 
 
Figure 1.6 Illustration of MSCs’ paracrine effects (Singer N G et al. Annual Review of 
Pathology: Mechanisms of Disease, 2011) 
Mesenchymal stem cells (MSCs) are the most studied cell candidates for stem cell 
therapy[36]. MSCs are adult stromal cells. They were first isolated and characterized from 
bone marrow in 1980s[37] and later found in almost every tissue: fat, skin, heart, muscle, liver, 
etc[38]. MSCs are self-renewable. They can be easily expanded in vitro after extraction. 
MSCs have multi-lineage differentiation potential. They were most known for their 
osteogenic, chondrogenic and adipogenic differentiation, but they can also differentiate into 
other mesodermal phenotypes like muscle cells in vitro. Besides their differentiation ability, 
MSCs are able to secrete a series of biomolecules which can induce tissue regeneration, 
vascularization, modulate immune function and suppress inflammation. This ability is called 






found of MSCs integrating with host tissue in vivo, it is generally believed that their 
therapeutic benefits were mainly due to their paracrine function [40].  
 
Figure 1.7 Common problems with minimally invasive delivery of cells. (A) Cells in 
suspension tend to settle, leading to uneven distribution of cells on delivery. (B) Cells 
may attach to the delivery system. (C) Cells tend to form aggregates that might impair 
their function and ease of administration. (D) Cell health will depend on the viscosity of 
the injected fluid, the cell size, the inner diameter and surface roughness of the needle, 
the ratio of needle diameter to reservoir (syringe barrel) diameter, the rate of infusion, 
etc. (E), Underdosing. Blind insertion can (F) miss the target site or (G) lead to 
backpressure, and leakage during infusion into a closed space could lead to cell damage 
and poor delivery. (H) Improper sealing of the needle track after delivery can lead to 
escape of the transplanted cells, particularly in muscle tissue, where compressive forces 
are higher. (I) Heterogeneous tissue structure may cause needles to deflect in an 
unpredictable manner away from the target site. (J) A large target site may require 
multiple injections, increasing invasiveness. (K) The injected fluid tends to travel along 
the path of least resistance (eg, along the fascia), which could cause cells to be dispersed 
away from the target site. Furthermore, cells may tend to migrate after delivery. (L) 
Clumps and inconsistent cell dispersion may result from delivery of a cell scaffold or 
carrier if the rate of infusion or scaffold gelation is poorly controlled. (O'Cearbhaill, 







The results from clinical studies were mixed. Many studies showed promising results 
in early stage clinical trials, but failed to meet the endpoint in phase III/IV trials.  One 
possible reason for this situation is the low engraftment of MSCs. Currently, in almost all 
clinical trials, MSCs were administered through intravenous or muscular injection. However, 
directly injected MSCs usually have very low retention. Studies showed that systemic 
delivery of MSCs to infarcted hearts yielded only 11% retention at 90 min and 0.6% 
retention at 24 h. Some problems of direct injection of cells were illustrated in Figure 1.5[41].  
This huge loss of cells resulted from both physical and biological factors. After 
administration, cell suspensions were quickly washed out in the in tissue cavities or from the 
injection hole because of lack of adhesion. Cells that survived acute loss also have to suffer 
from ischemic and inflammatory environment, which further reduced the cell retention. Such 
situation restricted the application of MSCs therapy greatly. 
Figure 1.8 Cell retention and engraftment in current studies. (Collins, Maria C., et 






Efforts have been made to increase the cell retention of stem cell therapy. For example, 
researchers have tried to deliver pre-conditioned cells. Ling et al. found that transplantation 
of hypoxia preconditioning treated BMSCs resulted in better functional recovery after stroke. 
They found hypoxia preconditioning upregulates pro-survival and pro-regenerative genes in 
BMSCs [42]. Wang et al. transplanted hypoxia preconditioned ADSCs and found enhanced 
therapeutic effects in diabetes induced erectile dysfunction rats. They found hypoxia 
precondition upregulated angiogenesis and neuroprotection genes including VEGF and its 
receptor FIK-1, angiotensin (Ang-1), bFGF, brain-derived neurotrophic factor (BDNF), glial 
cell-derived neurotrophic factor (GDNF), stromal derived factor-1 (SDF-1) and its CXC 
chemokine receptor 4 (CXCR4) [43]. Researchers have also tried genetic modification of 
MSCs through overexpressing prosurvival genes. For example, Dan et al. engineered MSCs 
with integrin-linked kinase (ILK), which is a pleiotropic protein critically regulating cell 
survival, proliferation, differentiation, and angiogenesis. They intracoronary injected ILK 
engineered MSCs in porcine MI model and found significantly increased functional recovery. 
They also found increased homing capacity to infarct myocardium with ILK engineered 
MSCs [44].  Another approach that has been adopted is cell surface modification. For example, 
Chi et al. incorporated a P-selectin glycoprotein ligand-1 (PSGL-1) mimetic 19Fc[FUT7+] 
onto surface of MSCs to enhance engraftment of MSCs. Currently they are still working on 
large animals to prove the efficacy of this method [45]. 
1.2.6 Scaffolds for MSC transplantation 
However, modification of cells alone can hardly reduce the acute loss caused from 
physical factors. To address this problem, scaffold based delivery strategy was brought 






before transplantation. Therefore, scaffolds could provide a friendly niche like native ECM 
with pre-established adhesion, preventing cell loss due to mechanical distribution. They can 
be classified into injectable scaffolds and cell patch according to their delivery approach.  
Injectable scaffolds can be divided in three categories: (1) hydrogel 
microencapsulation; (2) attachment with preformed microcarriers; (3) entrapment with in 
situ formed hydrogels after injection. hydrogel microencapsulation was first developed for 
the immunoisolation of islets 30 years ago [46,47]. In this approach, hydrogels beads of several 
hundred micrometers were formed in situ with cell suspensions. The hydrogel capsules are 
permeability controllable, which allows the diffusion of oxygen, nutrient and paracrine 
factors, and protect cells from the attack of immune system. For example, Jiashing et al. 
encapsulated MSCs in alginate microspheres and injected them in the myocardium of MI 
rats. They found this approach could lead to the maintenance of LV geometry, preservation 
of LV function, increase of angiogenesis and improvement of cell survival [48]. In second 
approach, the preformed microcarriers are usually made of micro-scale porous scaffolds. For 
example, Yaqian et al. loaded human MSCs in gelatin microcryogels, which are porous 
scaffold with scale of several hundreds of micrometers.  They injected the MSC loaded 
microcarriers to hind limb ischemic mice and found this strategy had superior therapeutic 
efficacy and prolonged cell survival [48]. The third approach for injectable scaffolds is 
through injection of a mixture of pre-gelation liquid and cells. The gelation should start 
shortly after injection, therefore provide adhesion and microenvironment of cells. For 
example, Eva et al. designed hydrogel consisting of silanized hydroxypropyl methylcellulose. 
This hydrogel is able to self-crosslink to form a scaffolding matrix. They intramyocardial 
injected MSC seeded hydrogel in rat model of MI and found this strategy had improved 






by injection procedure as illustrated in Figure 1.5. Meanwhile, hydrogels often show limited 
ability in cell adhesion and restrict ECM secreting and cell-cell interaction.  
 
Figure 1.9 Scaffolds for MSCs transplantation. (A)hydrogel microencapsulation, 
(B)porous microcarrier, (C)in situ formed hydrogel, (D)cell patch. (A: Landázuri, N, et 
al. Journal of tissue engineering and regenerative medicine, 2012；B: Y Li, et al. 
Proceedings of the National Academy of Sciences, 2014; C: Li L, et al. Advanced 
Materials, 2015; D: Kai D, et al. Acta biomaterialia, 2014) 
Cell patches are usually based on porous scaffolds, which are the most classic type of 
scaffolds for tissue engineering. Both synthetic and natural materials can be fabricated into 
porous scaffolds [51,52]. Comparing to injectable scaffolds, cell patches usually have better 
mechanical strength and could provide better adhesion of cells. The interconnected pores 
provide large surface area and enable fast mass exchange. In stem cell therapies, cell seeded 






loaded MSCs on PCL/gelatin electrospun fibers and implanted on the epicardium of MI rats. 
They observed restricted expansion of the LV wall, reduced scar size and increased density 
of the microvessels with this strategy [53]. Juli et al. loaded genetically engineered drug-
releasing human MSCs on PLA electrospun fibers and implanted in mouse model of brain 
cancer glioblastoma surgical resection. They found this strategy had a 5-fold increased MSC 
retention and 3-fold prolonged persistence over direct injected MSCs. The volume of 
established glioblastoma xenografts was also reduced in this study [54].  
As described above, currently most scaffolds adopted in MSC transplantation are 
traditional tissue engineering scaffolds like hydrogels or porous scaffolds. They often only 
display merits of a single material and also show a bulk property [55-58]. For example, 
hydrogels often show superior in vivo biocompatibility due to their high water content [59,60]. 
However, hydrogels with higher water content also tend to have weaker mechanical strength, 
which made them hard to remain integrity during preparation and after implantation. 
Therefore, composite material of hydrogels and porous scaffolds may optimize the 
biocompatibility and mechanical property and may be a good candidate for cell delivery. 
Meanwhile, most traditional hydrogels and porous scaffolds often only focus on 
recapitulating the native ECM on nano- to microscale, while lacking the ability to regulate 
spatial distribution of cells on larger scale and permeability of seeded cells. Therefore, a 
hierarchical structure design of scaffolds may offer regulation of cells in more aspects, which 







CHAPTER 2. DEVELOPMENT OF SCAFFOLDS WITH 
INTEGRATION OF HYDROGEL ON SURFACE OF POLYESTER 
MICROFIBER 
2.1 Introduction 
 Biodegradable hydrophobic polymers (e.g. polyesters), or plastics and hydrogels 
constitute two major categories of materials that have found important applications in 
fabrication of biomedical devices such as drug carriers, tissue scaffolds and wound dressings 
[61-66]. The two classes of materials, however, show distinctive characteristics as well as 
limitations. In particular, hydrophobic plastic polymers, which are mechanically tough and 
stable, can be conveniently fabricated with predefined structures and shapes. These 
properties make the polymer-based materials handy to maneuver and useful in a wide range 
of medical devices [67-69]. Hydrogels made of hydrophilic networks are capable of absorbing 
water and the hydrated systems often show superior biocompatibility in comparison to 
hydrophobic polymers by reducing the protein adsorption and displaying tissue-like 
elasticity [70]. However, hydrogels often exhibit relatively weak mechanical strength, and the 
materials may deform easily under pressured or water-vaporization conditions. These 
drawbacks have severely limited the use of hydrogels in design of medical devices. 
To address the limitations and develop tough yet bio-compatible materials, developing 
composite materials by integrating the hydrophobic polymers and hydrogel materials has 






through electrospinning processes not only exhibit high permeability and surface-to-volume 
ratio but also morphologically mimic the natural fibrous extracellular matrix (ECM). 
Electrospun fibers therefore have been intensively investigated for use as scaffolds for tissue 
repair. investigated for use as scaffolds for tissue repair [74-76]. Numerous efforts have been 
made to fabricate electrospun fiber-hydrogel composite materials [77-87]. Although materials 
with hydrogels filling up the pore spaces or fiber-hydrogel sandwiches were prepared, the 
important structural characteristics of fibrous materials—porosity and permeability—could 
not be maintained in many approaches. Moreover, as plastic fibers and hydrogels of different 
hydrophobicity are essentially incompatible, physical blending of the two components may 
result in defection in final matrices.  
Table 2.1 Limitation and merits of polyester fibers and hydrogels 
 
In this study, a new methodology for creating polyester-hydrogel fibrous hybrid 
matrices via inducing polymerization of hydrogels on the surface of electrospun fibers was 
reported. I hypothesized that if the polymerization of the hydrogel component could be 
localized and controlled at the fiber surface, a stable hydrogel layer ensheathing the fibers 
can be obtained to render new hybrid structure/properties. To investigate the concept, a 
trithiocarbonate-based chain transfer agent (CTA) was immobilized onto the surface of 






glycol) (PEG) hydrogel coating layers through surface reversible addition-fragmentation 
chain transfer (RAFT) polymerization. PEG-PCL hybrid materials of tunable morphologies 
were obtained. In contrast to the traditional polyester-based electrospun fiber, the matrices 
with fibers ensheathed in nanothin hydrogels display robust water-absorbing capability, non-
deformability, composite mechanical properties and superior biocompatibility. This facile 
methodology for creating porous plastic polymer-hydrogel hybrids can potentially be 
exploited to modify different types of porous scaffold materials, and therefore opens the door 
for fabricating new high-performance materials for biomedical applications. 
2.2 Materials and methods 
Materials 
Water was distilled and deionized using the Gelante Pure Water Equipment (Gelante 
Pure Water Co., Ltd., Shijiazhuang, China) at 18 M resistance. PCL (Mn ~ 70,000-90,000), 
polyethylene glycol diacrylate (PEGDA) (Mn ~ 575), N-hydroxylsuccinimide (NHS), NaOH, 
HCl （ 36% － 38% ） and deuterochloroform were purchased from Sigma-Aldrich 
(Milwaukee, WI, USA). Solvents including isopropanol， chloroform, dichloromethane, 
acetone, N,N-dimethylformamide (DMF) and carbon disulfide were from Beijing Chemical 
Works (Beijing, China). Trioctylmethylammonium chloride (Aliquat 336) and ethanethiol 
were purchased from TCI Shanghai (Shanghai, China). The suppliers of other chemical and 
biological reagents are specified in the text below. All 1H NMR experiments were performed 
with 400 MHz NMR equipment (ARX400, Bruker, Switzerland). 






A trithiocarbonate bearing the carboxylic acid group, S-ethyl-S’-(α,α’-dimethyl-α’’-
acetic acid)trithiocarbonate (EDAT),The trithiocarbonate CTA was synthesized according to 
a previously reported method [88]. 1.48 ml ethanethiol (0.020 mol) and 0.323 g Aliquat 336 
(0.80 mmol) were sequentially added to the acetone (12.5mL, 0.166 mol) in a round-bottom 
flask and the mixture was cooled to 10 °C under the nitrogen atmosphere. The NaOH 
solution (50%) (1.68 g, 0.021 mol) was then added dropwise, followed by a carbon disulfide 
(1.21 mL, 0.020 mol)/acetone (2.6 mL, 0.035 mol) mixture was added over 20 min. After 10 
min, chloroform (2.42mL, 0.030 mol) was added in one portion, followed by dropwise 
addition of 50% sodium hydroxide solution (8.00 g, 0.100 mol) over 30 min. The reaction 
was then allowed to react overnight under room temperature. To collect the product, the 
reaction solution was rotary evapora to rid of the acetone. The residue was then redissolved 
in 25 mL of water, and concentrated HCl was added under vigorously stirring at 5-10 °C to 
neutralize the base in the solution. The aqueous solution was then extracted three times with 
hexane, concentrated via rotary evaporation, and washed three times with water. The 
solution was dried by anhydrous sodium sulfate and isolated by column chromatography 
(silica gel 200-300 mesh) using ethyl acetate:hexane (2:3 v/v) as an eluent. After removal of 
solvent by rotary evaporation yielded an orange-brownish oil, which was dissolved in a 
small amount of hexane and washed three times with water. The solution was dried with 
anhydrous sodium sulfate again and crystallized at -20 °C. After recrystallization in hexane 
twice, yellow crystals were achieved as the final product. (1.2 g, yield: 28%) 1H NMR (400 
MHz, CDCl3): δ =3.30 (q, 2H), 1.73 (s, 6H), 1.34 (t, 3H).  






EDAT (1.00 g, 4.46 mmol) and the coupling catalyst, N,N'-dicyclohexylcarbodiimide 
(GL Biochem, Shanghai, China) (1.375 g, 6.67 mmol), were dissolved in 30 mL 
dichloromethane and cooled to 10 °C under nitrogen atmosphere. To this solution was added 
dropwise NHS (0.768 g, 6.67 mol) dissolved in 20 mL dichloromethane and the mixture was 
stirred and maintained overnight at room temperature. The solution was then concentrated by 
rotary evaporation and the EDAT-NHS product was isolated by column chromatography 
twice (silica gel 200-300 mesh) using ethyl acetate:hexane (3:1 v/v) as an eluent. The crude 
product, collected upon removal of the eluent, was redissolved in hexane and recrystallized 
at 4 °C, and the final pure product obtained as bright yellow powders. (1.12 g, 3.67 mol, 
yield: 78%) 1H NMR (400 MHz, CDCl3): δ =3.30 (q, 2H), 2.82(s, 4H), 1.73 (s, 6H), 1.34 (t, 
3H)  
Fabrication of PCL electrospun membrane 
The PCL fibers were fabricated using an electrospinning apparatus assembled in the 
laboratory. First, 1.5 g PCL was completely dissolved in a 10 mL chloroform/DMF (9:1 v/v) 
binary solvent under vigorous stirring to prepare a 15% (w/v) solution. 1 mL of this solution 
was then loaded into a 1 mL syringe (Shanghai Zhiyu Medical Material Co., Ltd, Shanghai, 
China) mounted on a syringe pump (WZS 50-F6，Zhejiang University Medical Instrument 
Co., Ltd, Hangzhou, China). A blunt-ended 22-gauge stainless-steel needle was installed 
onto the syringe and then connected with to the positive electrode of a high voltage supply 
(EST-801A，ESD-China, Beijing, China). The electrospinning was conducted for 2 h with a 
grounded steel plate was used as collector, and the processing conditions, the flow rate, 
collection distance, and applied voltage were maintained at 0.5 mL/h, 14 cm, and 12 kV, 






from the collector, cut into defined geometries (typically 7 mm × 7 mm square shape), and 
stored for further reaction and characterization. 
Coupling of trithiocarbonate CTA onto the surface of the PCL fiber 
To modify the trithiocarbonate CTA onto the surface of PCL fibers, a 10% (w/v) 1,6-
hexanediamine (Alfa-Aesar, Ward Hill, Massachusetts, USA) solution was first prepared by 
mixing 1.18 mL 1,6-hexanediamine with 8.82 mL isopropanol. PCL electrospun fibres were 
immersed in the solution and reacted 1h at 37°C in a sealed container. After reaction the 
PCL electrospun fibres were rinsed thoroughly with deionized water and isopropanol three 
times each.  
The aminated PCL electrospun fibers were soaked in a 4 mg/mL EDAT-NHS solution 
prepared in isopropanol with 1 μL/mL triethylamine (Xilong Chemical, Guangzhou, China) 
as catalyst. After incubating 1 h at 37°C, the CTA modified PCL electrospun fibers (PCL-
EDAT) were washed extensively with deionized water and isopropanol three times each and 
dried under vacuum.  
RAFT polymerization of PEGDA on the surface of the PCL-CTA fiber 
Three samples with PEGDA concentration of 5%, 7.5% and 15% (v/v) were 
synthesized. PEGDA, EDAT and the initiator, 4,4’-azobis[2-(imidazolin-2-yl)propane] 
dihydrochloride (VA-044) (J&K Chemical Ltd., Beijing, China) were added to a 25 mL 
round-bottom flask with [PEGDA]:[EDAT]:[Initiator]= 217:1:2. Reactants were dissolved 
deionized water with a total volume of 5 mL. The CTA-modified PCL matrices were 
immersed in the solution, the flask was sealed and deoxygenized by nitrogen bubbling for 40 






h. After reaction, PEGDA surface polymerized electrospun fibers (PEG-PCL) were 
extensively washed by vortex in deionized water and dried in vacuum.  
The addition of PEGDA hydrogel was shown by Fourier transform infrared 
spectroscopy (FTIR) instrument by the attenuated total reflection (ATR) method. (Nicolet 
750,USA) Samples were dried overnight under vacuum before testing.  
Analysis of the amine content in PCL matrix treated by aminolysis 
1 mg of PCL or NH2- PCL electrospun fibrous sample was added in 4 mL of 2.5 
mg/mL ninhydrin DMSO solution. The mixture was heated in water bath at 80 °C for 15 min 
until the polymer dissolved and fully reacted with ninhydrin. The absorbance of the solution 
at 600 nm was measured by a microplate reader. The NH2 concentration of PCL or NH2- 
PCL samples was calculated from the standard curve and compared. 
Microscopic spectroscopic characterization  
To obtain the morphological characteristics of different PCL fibers, different PCL 
membrane samples were gold sputter-coated and examined by the scanning electron 
microscope (SEM) (S-4800, Hitachi, Japan). ImageJ was applied to quantitatively 
characterize the fiber diameter. For each sample, 10 randomly selected fibres were counted 
in each image, with a total of 3 images.  
Wetting and water-absorption properties of PCL and PCL-PEG hybrid membranes 
The wetting property of PCL and PCL-PEG hybrid membranes was studied by 
measuring the contact angle of water on different membranes through the static sessile drop 






dropped through the tip of a syringe onto the selected region of a membrane surface. After 1 
s equilibrium, the droplet and the surface were imaged by the horizontal microscope 
connected to the CCD camera. If the droplet were visible on the surface, the contact angle 
was measured. For each membrane sample, at least three measurements were performed with 
water dropped on randomly selected spots on the surface.  
To study the water-absorption property of the fibrous PCL and PCL-PEG materials, 
each thoroughly dried mats were weighed on a micobalance and then separately immersed 
and hydrated in 5mL deionized water for 1 min. The samples were then removed from the 
water, blotted dry with kimwipes tissue paper (KIMTECH, Roswell, U.S.) before the 
weights were recorded again. The water uptake capacity of the sample was calculated 
according to the equation: water uptake (%) = (Wt – W0)/W0 × 100%, where Wt and W0 is 
the weight of the hydrated and dry mats, respectively.  
According to the water contents in the hybrid  materials, the  PEG composition in the 
hybrids may be calculated according to the equation:  
percent PEG mass in hybrid = percent water content in hybrid/ (1- PEG%) × PEG%. 
In this equation, the PEG% theoretically should be the PEG concentration in the hydrogel 
layer on the fiber surface. One assumption can be made is that the PEG concentration in the 
hydrated hydrogel layer on the fiber surface was the same as the feed ratio in the surface 
polymerization. Although the results were estimation, the calculation reflected the 
approximate PEG composition in the hybrids. 






To understand the mechanical property of the hybrid materials, local fiber surface 
mechanical properties were determined by AFM indentation using atomic force microscopy 
(AFM) (SPI3800, NSK LTD., Japan) equipped with Budgetsensors tap 300 AI-G AFM tip, 
which had a spring constant of 40 N/m. PEG-PCL samples were hydrated before testing. 
Images were scanned through contact mode to locate fibres. AFM tip was then placed on top 
of a fiber and start indentation. The force-displacement curve of sample was obtained during 
the indentation of AFM tip on fibers.  
To study the tensile strength of the fibrous materials, electrospun PCL and PCL-PEG 
hybrid membranes of approximated 200 μm thickness were prepared as described above. 
The fibrous membranes were then cut into rectangular strips of 3×1 cm2, and fixed on the 
mechanical tester (AGS-X Series Table-top Precision Testers, Shimadzu, Japan) with two 
ends clamped. The testing area was 1.5 × 1 cm2 and stretched at a speed of 5 mm/min until 
break. The tensile strength, elongation and elastic modulus were calculated from the stress-
strain curve. Four samples were tested for each type of membrane.  
Cell adhesion on PCL and 7.5% PEG-PCL membranes 
PCL or 7.5% PEG-PCL membranes were cut to 5 mm × 5 mm squares and sterilized 
via immersion in 75% ethanol for 30 min. The membranes were thoroughly washed three 
times by DPBS and place on 96-microwell plates (ULAPs, Corning, NY). Human Adipose-
derived stem cells (hADSCs) were kind gifts from Dr. Xiumei Wang’s lab, Tsinghua 
University. Each membrane was seeded with 3000 cells and incubated under 37 °C and 5% 
CO2 for 24 h. The supernatants were removed and the membranes gently washed by warm 
DPBS for three times. The cells were then fixed in 4% paraformaldehyde (Beijing Chemical 






Carlsbad, CA). The samples were imaged under a laser scanning confocal microscope (A1R-
si, Nikon, Tokyo, Japan) 
Subcutaneous implantation of PCL and PCL-PEG hybrid materials 
Subcutaneous implantation was performed to evaluate the host reaction to the hybrid 
membrane. All procedures were performed in accordance with the regulations approved by 
the Institutional Animal Care and Use Committee (IACUC) of Peking University. Modified 
and non-modified electrospun materials were soaked in 70% aqueous ethanol for 30 min and 
thoroughly washed with sterilized DPBS three times before implantation. The Sprague 
Dawley rats (Vitalriver, Beijing, China) weighing 290-320 g were anaesthetized with an 
intraperitoneal injection of chloral hydrate (400 mg/kg body weight). The abdomen was 
shaved and swabbed with betadine and a midline incision was made in the skin. Two pockets 
were created by blunt dissection in the dermal layer on both sides of the midline. One PCL-
PEG and one PCL fibrous membranes were then placed into the left and the right side pocket, 
respectively. Incisions were closed with sutures and the animals were observed until 
recovery and housed for prescribed time.  
Animals were sacrificed post implantation by CO2 asphyxiation. The implants and the 
surrounding tissue were harvested from the killed rats, fixed in 4% paraformaldehyde, 
dehydrated with graded ethanol solutions and embedded in paraffin via standard procedures. 
The samples were sliced on a microtome at a thickness of 5 μm. The sections were stained 
with hematoxylin and eosin (H&E) and then imaged by an upright microscope (Olympus 
DP71, Japan). The presence of inflammatory cells was analyzed by a professional 
pathologist, Yong-Jian Deng of the Department of Pathology at Southern Medical University 







All quantitative measurements were presented as mean ± standard deviation (SD). The 
one-way analysis of variance followed by Tukey’s post hoc analysis was performed to 
compare the multi-group data. The unpaired t-test was performed when the data was 
consisted of only two groups. The level of significance was labeled by *, ** and ***, 
denoting the p value of <0.05, <0.01, and <0.001, respectively. 
All results were presented as mean ± standard deviation. Unpaired t-test was 
performed using SigmaStat statistical software. Differences were statistically significant at 
P<0.05. 
2.3 Results and discussion 
 
Figure 2.1 (A) Synthesis and functionalization of the chain transfer agent, EDAT. (B) 
Schematic illustration of the RAFT polymerization of PEG-DA on the PCL electrospun 







Figure 2.2 (A) 1H-NMR spectrum of EDAT, (B) 1H-NMR spectrum of EDAT-
NHS(Wang J Y, et al. ACS Biomaterials Science & Engineering, 2016.) 
The reactions and process for fabricating the hybrid PEG-PCL materials is 






synthesized and confirm through 1H-NMR (Figure 2.2 A and B). The quantity of NH2 group 
after aminolysis of PCL fiber was confirmed through ninhydrin assay (Figure 2.3). The 
incorporation of PEG in the electrospun fibers was investigated via FTIR spectroscopy. 
Given that C–O bonds were more abundant in PEG than in PCL, the absorption peak near 
1100 cm-1 corresponding to the C–O stretching band was used to identify the PEG 
component. As shown in Figure 2.4, higher peak intensities at 1100 cm-1 were observed in 
the PEG-modified PCL samples and the intensity increased with the initial PEGDA 
concentration, which may be due to higher amounts of PEG in the hybrid matrices. 
The incorporation of PEG was also investigated via imaging the fiber morphology, 
which was found to vary with the PEG concentration. The pristine PCL electrospun matrices 
contained the typical non-woven microfibers bearing relatively smooth surfaces, with the 
fiber diameters around 1.5 μm. (Figure 2.5 A) In the 5% PEG-PCL samples, the fibrous 
morphology was preserved, but the fiber surface became rough with some cornered region 
filled with gel-like materials; the average fiber diameter increased to 1.9 μm. When the PEG-
DA concentration was improved to 7.5%, the fibrous morphology was also clearly 
maintained, but all the fibers were covered with heavily wrinkled skin layers with the 
average fiber diameter reaching approximately 3.5 μm. (Figure 2.5 B) The fibrous structures 
were unobservable in the 15% PEG-PCL samples; instead, the matrix exhibited a gel-like 
morphology containing closed pores with size of around a few micrometers. It was assumed 
that if the fibers were wrapped homogeneously with PEG hydrogels, the PEG thickness was 
around 180 nm and 1 μm in the 5% PEG-PCL and 7.5% PEG-PCL matrices, respectively. 
The morphology suggests that the RAFT polymerization occurred and localized on the fiber 
surfaces. Interestingly, the wrinkles in the 7.5% PEG-PCL may be caused by the shrinkage 






wrinkling is a characteristic surface behavior of an elastic film when the surface bends over 
compressed substance (e.g. water) on rigid surfaces. 
 
Figure 2.3 Analysis of the amine content in PCL fibers after aminolysis(Wang J Y, et al. 
ACS Biomaterials Science & Engineering, 2016.) 
 
 
Figure 2.4 FTIR spectra of 15% PEG-PCL (green), 7.5% PEG-PCL (red) and PCL 
(blue) samples. The enhanced peak at 1100 cm-1 corresponding to the C–O bonds in 








Figure 2.5 SEM images of PCL electrospun fibers and different hybrid matrices. (A 
and B) pristine PCL fibers, (C and D) 5% PEG-PCL, (E and F) 7.5% PEG-PCL, (G 
and H) 15% PEG-PCL. The boxed areas in A, C, E and G are magnified in B, D, F and 
H respectively. (Wang J Y, et al. ACS Biomaterials Science & Engineering, 2016.) 
 
 
Table 2.2 The average fiber diameter, the water contact angle, water uptake and PEG 
mass percentage of PCL electrospun fibers and different hybrid matrices. (Wang J Y, 








Figure 2.6 Images of measuring water contact angles of (A) PCL electrospun fibers and 
(B) 7.5% PEG-PCL, with 7.5% PEG-PCL showing a highly hydrophilic surface (Wang 
J Y, et al. ACS Biomaterials Science & Engineering, 2016.) 
The incorporation of PEG also increased hydrophilicity of the original matrices. When 
in contact with water droplets, the PCL fibers were water-repelling and relatively large 
contact angles recorded. In all the PEG-PCL composite samples, the water droplets were 
observed to wet the surface instantly, thus the composite materials are highly hydrophilic. 
More interestingly, it was noted that the PEG-PCL samples were capable of absorbing water 
and the amounts of water in the matrices were measured from 50% to 140% of the mass of 
the dry matrices. Among the three types of composites, 7.5% PEG-PCL seemed to have 
highest level of water uptake, although no statistical difference between 15% PEG-PCL and 
7.5% PEG-PCL was observed. (Table 2.2) As the hydrogel layers around the fibers were 
relatively thin and all matrices were porous, the matrices achieved equilibrium with water 
within a few seconds and no swelling or deformation was visually noticeable. The resulting 
composite materials thereby are superior to pure hydrogels in terms of the ability to allow 
fast-speed water absorption while maintain micro- and macro-scale shapes/structures: the 








Figure 2.7 (A) Averaged tensile stress–strain curves of 7.5% PEG–PCL and PCL 
electrospun fibers. (n = 4, mean ± STD). (B) Comparison of elastic modulus, stress at 
280% strain and tensile strength according to tensile tests in A. (C, D) Representative 
force–displacement curves obtained from AFM indentation tests on PCL and 7.5% 
PEG–PCL electrospun fibers, respectively. (E) Comparison of force/displacement ratio 
in the loading curve in C and D (n = 9, mean ± STD; ***: p < 0.001) (Wang J Y, et al. 






Mechanical properties are essential to the function/performance of biomaterials in vitro 
and in vivo. To understand how the PEG sheath alters the mechanical properties of 
electrospun fibrous matrices, tensile and AFM indentation tests were performed to 
characterize the macroscopic and local mechanical properties of the materials, respectively 
[89,90]. 7.5% PEG-PCL samples, the matrices containing PCL fibers with relatively thick PEG 
hydrogels, were compared with pristine fibrous PCL. It is seen that the tensile stress-strain 
curves of PEG-modified or non-modified matrices both show the mechanical characteristics 
of ductile materials. (Figure 2.7 A) At low strain levels, the two types of materials exhibited 
similar Young’s moduli. (Figure 2.7 B) After the yield point--approximately at 40% 
elongation, the stress continued to increase on the account of strain hardening. However, 
higher stresses were observed in 7.5% PEG-PCL than the pristine PCL samples; in particular, 
the stress at 280% strain was approximately 33% higher. (Figure 2.7 B) It is speculated that 
the extra stress in stretching the composite matrices may originate from the compressed 
hydrogels between PCL fibers and were orthogonal of the stretching direction. When the 
plastic necking started, the curves coincided again and the two types of materials showed 
approximately the same stress and strain near rupture. (Figure 2.7 A and B) These results 
suggest that the PCL dominates the macroscopic property of the composite materials, and the 
high moduli and strechability characteristic of plastic materials were maintained in the 
hybrids.  
In contrast to the tensile tests, the AFM indentation applies indentation to a small area 
on material surfaces and measures the load force and surface displacement. The data thereby 
reflects the local or surface mechanical properties of materials. Figure 2.7 B shows the 
representative indentation force-displacement curves recorded for 7.5% PEG-PCL and PCL 






the 7.5% PEG-PCL matrices–at the scale of only a few nano Newtons–were much smaller 
than the PCL samples. The linear fitting of the loading curves showed that the force-
displacement slope of the PCL was over two orders of magnitude greater than 7.5% PEG-
PCL. This result indicates that different from the macroscopic behavior, the mechanics at the 
fiber surface is determined by the hydrogel components.  
Hydrogels often demonstrate superior biocompatibility due to the advantage of 
hydrophilic surfaces in mediating the interactions with proteins and tissues. As the surface is 
prone to repelling the protein adsorption, hydrogel surfaces often show minimal adhesion to 
cells and tissues. When cells were seeded on the 7.5% PEG-PCL and PCL matrices, the cells 
formed aggregates on the former while adhered and spread on the latter, indicative of low 
cell adhesion on PEG-modified PCL fibers (Figure 2.8). 
 
Figure 2.8 Representative images of hADSCs seeded on PCL and 7.5% PEG-PCL 
membranes. Cells were fixed and stained with rhodamine-phalloidine and DAPI to 
show F-actin (red) and nucleus (blue), respectively. (Scale bar: 100 µm) (Wang J Y, et 









as well as thinner and looser collagen deposition were observed surrounding 7.5% PEG- 
 
The 7.5% PEG-PCL and PCL electrospun membranes were implanted subcutaneously 
at the abdominal site in rats to further investigate the biocompatibility of the composite 
materials in vivo. In the micrographs of the histological sections (Figure 2.9 A-D), fewer 
number of macrophage/foreign-body giant cells (FBGCs) (Figure 2.9 E) were found in 7.5% 
PEG-PCL PCL in comparison to PCL matrices following the 4-week implantation. 
Interestingly, like the PCL matrices, the 7.5% PEG-PCL matrices also allowed cell invasion 
Figure 2.9 Representative H&E stained histological sections of explanted PCL 
matrices (A, B) and 7.5% PEG-PCL (C, D) after four-week subcutaneous 
implantation. The boxed areas in (A) and (C) are magnified in (B) and (D), 
respectively. Asterisks, arrows and arrowheads indicate the area of matrices, blood 
vessels and foreign body giant cells (FBGCs), respectively. Scale bars: 100 μm (A, C) 
and 50 μm (B, D). E) and F), quantitative and statistical analysis of the number of 
FBGCs (E) a d blood vessels (F) surrounding the implants, respectively. Data were 
analyzed using unpaired Stu-dent’s t-test. (n = 4, mean ± STD). (Wang J Y, et al. 






with small blood vessels observable at the tissue-implant interface. (Figure 2.9 F) The result 
suggests that the PEG modification did improve the biocompatibility of electrospun fibers 
without hampering the original porous structure necessary for cell scaffolding. 
RAFT polymerization has been investigated for creating various biomaterials such as 
bioactive polymers/conjugates for drug delivery applications [91-95] and surfaces that 
prohibiting adhesion of bacteria [96]. Here, it is the first time that RAFT polymerization was 
performed to synthesize hydrogel coatings on the surface of plastic fibers. Given the low 
toxicity of the initiator and CTA, the mild polymerization conditions should also be 
cytocompatible. The methodology thereby is potentially applicable to fabricating materials 
in presence of biomolecules and cells. 
In addition to the methodology, the PEG-modified matrices demonstrate a new type of 
porous hybrid material. In the literature, the main approaches to fabricate fiber-hydrogel 
composites include: 1) directly embedding preformed electrospun fibers in hydrogel 
precursor solutions and crosslinking the hydrogel reagents [97-101] and 2) dual 
electrospinning/electrospray, in which the polymer and hydrogel precursor solutions were 
simultaneously electrospun/electrosprayed on the collector and then crosslinked [102-104]. 








Figure 4.10 Swelling of traditional hydrogels after hydration. (Zhong X, Dehghani F.. 
Green Chemistry, 2012, 14(9): 2523-2533.) 
In our study, hydrogel was chemically bonded to the fiber surface and thereby is 
relatively stable in the hybrids. More importantly, since the hydrogel coatings on PCL fibers 
were nanothin, the pores in the original PCL matrices were preserved (5% PEG-PCL and 7.5% 
PEG-PCL). This allows anchored expansion of the thin hydrogel coating layers, and the 
process did not cause visible changes to the gross volume, macroscopic structures or the bulk 
mechanical property of the matrix. In contrast, upon hydration, conventional hydrogel 
matrices often experience significant expansion of the volume/shape and drop of mechanical 
properties. The hybrid materials created here therefore present plastic fibers capable of 
“invisible” hydrogel swelling due to the unique thin coating structure. 
The materials developed in this study can be used as scaffolds or to guide specific 
interactions with cells. The mechanical characterization suggests that PEG-modified PCL 
matrices exhibit plastic strechability with a low surface elasticity, indicating a composite 
property that is otherwise non-achievable through plastics and hydrogels alone. The 
electrospun fibers therefore provide a unique type of cell-invasive scaffolds containing high-






both the skeleton and the surface hydrogels can be tuned for induction of beneficial cell 
responses. The CTA remaining on the hydrogel surfaces also have the potential to allow 
tethering of other molecules for specific biological activities such as adhesiveness toward 
cells [110]. It is also possible to incorporate therapeutics in the plastic skeleton or the gel layer 
for designing drug-delivery devices. 
2.4 Conclusion 
To summarize, a new type of fibrous matrices with microfibers ensheathed with 
hydrogels of controllable thickness was successfully developed through a RAFT 
polymerization of PEG oligomers on the surface of PCL electrospun fibers. The hybrid 
materials exhibit versatile mechanical properties, surface biocompatibility and cell-material 
interactions that reflect the features of the composite fibrous structure. The facile, water-
based methodology is applicable to modifying the surface of other types of porous or non-
porous materials to create hybrid materials, and the nondeformable, water-absorbing fibrous 







CHAPTER 3. DEVELOPMENT OF MICRO-WELL ARRAY 
PATTERNED SCAFFOLDS AND THEIR APPLICATION IN 
MESENCHYMAL STEM CELL TRANSPLANTATION 
3.1 Introduction 
To better mimic the natural ECM structure, classic scaffolds such as electrospun fibers 
and hydrogels are commonly designed to have pores of a few microns in diameter. Such 
micro-structures usually affect the cells on a cellular/subcellular level by modulating the 
local biochemical, biomechanical, and mass transport microenvironment to promote cell 
viability and function. With the rapid advancement in stem cell technologies, different 
microscale tissues or organoids have been produced through scalable processes. These 
microtissues often exhibit superior therapeutic functions to single cells. To successfully 
transplant those microtissues, scaffolds should have the ability to not only control 
microenvironments on cellular/subcellular level, but also manipulate their spatial distribution 
on a larger scale (hundreds of microns to a few millimeters) to promote efficient 
vascularization and prohibit hypoxia and insufficient nutrient supply caused by random cell 
clumping. In this chapter, the design of a scaffold with control over both microenvironments 
and spatial distribution by fabrication of microwell patterned electrospun fibers will be 
demonstrated. The scaffolds’ potential in microtissue transplantation by transplanting MSC 
spheroids in a mouse model of hind limb ischemia is also discussed in this chapter. 
Stem cell therapy has gained vast interest recent years as a promising approach for a 






Unlike ES and iPSCs, MSCs have no ethical concerns and no potential for teratoma 
formation and much less complicated preparation process, which made them the most 
studied cell source for stem cell therapy [111-117].  
However, currently a major challenge in MSCs therapy is the low cell retention and 
viability. In most studies, MSCs were administered as single cell suspension through 
systemic or local injection [118,119]. Though MSCs possess the ability to home to pathological 
tissue after systemic infusion, the efficiency is usually very low and most cells were found 
trapped in capillaries of organs such as lung, liver and spleen [120,121]. During local injection, 
in a common case where MSCs are delivered in closed space like muscle, cells suspensions 
are likely to leak from the injection hole due to backpressure [122]. After injection, large 
amount, up to 85% of cells were lost by acute wash out into circulation within hours and 
those retained at injury site had to stand the ischemic and inflammatory environment, which 
further reduced cell survival [123]. In most studies, injected MSCs disappeared within 7 days.  
Cell premodification is a common approach to improve cell viablity after 
transplantation. There are techniques such as hypoxia preconditioning [124-126], genetic 
modification through overexpressing prosurvival genes [127-131] or cell surface modification 
of adhesive peptides [132]. I am particularly interested in exploiting the application of the 3D 
assembly of MSCs, MSC spheroids. Several studies including ourselves’ have found that the 
three dimensional (3D) MSC spheroids have improved paracrine function as their anti-
apoptosis, angiogenic and anti-inflammatory genes are greatly upregulated and higher 
amounts of corresponding factors are secreted compare to single layer cell culture [133-135]. 
This functional enhancement is likely due to the increased cell-cell, cell matrix interaction 






could benefit both cell survival and therapeutic effect after transplantation. In addition, 
because of the increased cell density of spheroids, the released paracrine factors would also 
have a higher local concentration, resulting a more protective local environment [136].   
Manipulation on cells alone can hardly ameliorate the low cell retention caused by 
mechanical dispersion. Therefore, biomaterials based cell delivery strategy was developed to 
solve this problem. The pre-established cell-material adhesion could provide protection 
against acute cell loss. In clinical MSC therapies, smaller transplantation volume with higher 
cell transplantation density is greatly desired due to 1) a smaller transplantation volume 
could reduce the chance of leaking and mechanical dispersion when cells are injected to a 
tissue with limited space, which would increase the cell retention in physiological area, 2) 
higher local cell concentration could generate higher paracrine factor concentration and 
benefit therapeutic outcome. However, high cell density would inevitably cause random cell 
clumping that leads to hypoxia and decrease cell viability, especially when multicellular 
spheroids are applied. In order to achieve both high cell density and good cell viability, 







Figure 5.1 Cells death caused by random cell clumping. (Red: dead cells, Green: living 
cells, Wang X, Wang K, Zhang W, et al. Biomaterials, 2017.) 
Conventional foam-like or nonwoven fibrous scaffolds could provide 
microenvironments on cellular level, however, they may lack control spatial organization of 
cells/microtissues. Micropatterning technique can regulate the spatial regulation of cells. 
However, most micropatterning technology were conducted on PDMS or hydrogels. PDMS 
lacks control of microenvironment and is limited in mass transfer. Hydrogels are weak in 
mechanical strength, as has been addressed intensively in this dissertation. Therefore, in this 
study, I seek to develop a scaffold with control of both microenvironment and spatial 
distribution. To achieve his goal, micropatterning was introduced on electrospun fibers. 
MSC spheroids together with the micropatterned scaffold were further transplanted in a 
mouse model of hind limb ischemia with focus on ameliorating cell retention and tissue 
vascularization. 







Polycarbonate-polyurethane copolymer was achieved from DSM biomedical company 
(Berkeley, CA, USA). Tetrahydrofuran (THF) and dimethyl formamide (DMF) were 
purchased from Beijing Chemical Works (Beijing, China). The cell culture plates and low-
attachment culture plates were from Corning (NY,USA). Dulbecco’s phosphate-buffered 
saline (DPBS) was purchased from Invitrogen (Carlsbad, CA, USA). Bone marrow derived 
MSC from BALB/C and culture reagents were purchased from Cyagen (Santa Clara, CA, 
USA). The suppliers of other chemical and biological reagents are specified in the text below. 
Fabrication and characterization of microwell-patterned scaffold 
The microwell-patterned scaffold was fabricated by a combination of electrospinning 
and micromolding method. Figure 1A illustrates the fabrication of microwell-patterned 
scaffold. Briefly, conductive PDMS replicas were fabricated by curing the mixture of PDMS 
prepolymer, crosslinking catalyst and conductive carbon black on microwell patterned 
master silica wafer. 8% (w/v) CarboSilTM thermoplastic silicone polycarbonate urethane 
(TPU) solutions were prepared by dissolving the TPU in a 3:2 (v/v) mixture of 
tetrahydrofunan (THF) and N, N-dimethylformamide (DMF). The TPU solution was 
electrospun onto the conductive PDMS replica. The flow rate of the syringe pump was set at 
0.5 mL/h, the distance between the needle and the PDMS collector was 13 cm and the 
voltage was 12 kV. The microwell patterned scaffolds were achieved by peeling off the 
membrane from the PDMS collector. To study the morphology of PU-mw, membrane 
samples were gold sputter-coated and examined by the scanning electron microscope (SEM) 
(S-4800, Hitachi, Japan). 






To generate the MSC spheroids, MSCs were seeded on an ultra-low attachment 24-
well microplate at 100,000 cells per well. The microplate was placed on an orbital shaker 
and rotated at 160 rpm for 1 h and placed in incubator for another 23h.  
Before loading spheroids, scaffolds were placed on the bottom of a 24-well microplate, 
with the microwells facing upwards. Then they were washed thoroughly in 75% ethanol and 
DPBS 3 times each and left to dry. MSC spheroids collected from aspiration from 4 wells 
were combined together. After centrifugation at 500 rpm for 5 min, spheroids were 
resuspended in 500 μL medium. The spheroids suspension was added to the scaffold 
followed by another centrifugation at 500 rpm for 5min. After incubation for 24 h, spheroids 
seeded scaffold were stained with DAPI and FITC-phalloidin and observed under confocal 
microscope (Zeiss LSM 510, Oberkochen, Germany). 
Real-time PCR assay 
The MSC spheroids or monolayers cultured for 24 h were collected and homogenized. 
The total RNA was extracted from 4×105 cells using the RNeasy® Mini kit from Qiagen 
(Hilden, Germany) according to the manufacturer’s instructions. After the determination of 
RNA concentration by Biophotometer (Eppendorf, Hamburg, Germany), 2 μg of the pure 
total RNA was transferred and reverse transcribed. The primers are listed in the 
Supplementary Material. The gene expression levels were then quantified and analyzed 
using the SYBR Green real-time polymerase chain reaction (PCR) method by the Applied 
Biosystems StepOnePlus PCR system (Foster City, CA, USA). The primers were all 
obtained from Qiagen. Copy numbers of each gene were calculated by standard curve 
method. All gene expression values were normalized to 18S level. Each RNA sample was 






Transplantation of MSC spheroids in mice model of hindlimb ischemia (HLI) 
All protocols were approved by the Institutional Animal Care and Use Committee of 
Emory University. Male 129 mice (Charles River, MA, USA), 8 weeks old were used. The 
mice were anaesthetized with 1–2% isoflurane. The superficial femoral artery and vein were 
ligated proximal to the deep femoral artery and tibial arteries, and the portion between the 
ligation points was excised. Before transplantation of MSC spheroids seeded scaffolds or 
scaffold alone, each scaffold was cut to 0.4 cm2 semi-circle to fit the shape of thigh muscle. 
During transplantation, each scaffold was rinsed in DPBS and placed on top of the thigh 
muscle with microwells facing towards to the muscle tissue right after the excision of artery. 
For MSC or MSC spheroids groups, 2×105 cells or spheroids with equivalent cell number 
were suspended in 40 μL DPBS and injected into the ischemic thigh muscle. 
Measurements of hindlimb perfusion by laser-Doppler perfusion imaging (LDPI) 
LPDI with a laser of 810 nm (MoorLDI, Moor Instruments, Wilmington, DE, USA) 
was used to evaluate perfusion at various days after HLI. The perfusion ratio was calculated 
by dividing the mean perfusion of thigh and proximal leg in the ischemic leg by that in the 
non-ischemic leg for each animal. 
Histology and the determine of blood vessel density 
Animals were sacrificed by CO2 inhalation at 7 days after HLI. Sections from ischemic 
thigh were obtained after fixation in formalin and embedment in paraffin. To stain the blood 
vessels, sections were deparaffinized and stained with a primary antibody, biotinylated lectin 
(Vector Laboratories, Burlingame, CA, USA), followed by a second antibody, streptavidin 






with DAPI and observed under fluorescent microscope (Axioskop 2 Plus, Zeiss) using long 
pass filter. 
Bioluminescence imaging 
MSCs were transduced with a lentivirus expressing firefly luciferase, GFP and 
blasticidin resistance under the control of the constitutively active cytomegalovirus and 
respiratory syncytial virus promoters, respectively (GenTarget, San Diego, CA). 72 h after 
transduction, MSCs were transferred into standard media containing 10 μg/mL blasticidin 
(Sigma-Aldrich, St. Louis, MO, USA). Luciferase expression was confirmed with the GFP 
under fluorescence microscope. Animals were introperitoneally injected with luciferin 40 
mg/kg 30 min before imaged using Bruker in-vivo Xtreme imaging system (Billerica, MA, 
USA). Luminescence was quantified in the thigh region using Bruker molecular imaging 
software. 
Statistical analysis 
All quantitative measurements were presented as mean ± standard deviation (SD). The 
one-way analysis of variance followed by Tukey’s post hoc analysis was performed to 
compare the multi-group data. The unpaired t-test was performed when the data was 
consisted of only two groups. The level of significance was labeled by *, ** and ***, 
denoting the p value of <0.05, <0.01, and <0.001, respectively. 
3.3 Results 











Figure 3.3 Macroscopic (A) and SEM images (B and C) of microwell patterned scaffold.  
Figure 3.3 shows the macro and micro structure of the microwell-patterned scaffold. 
The scaffold is composed of electrospun fibers with diameters of 0.28 ± 0.05 μm. The 
microwell patterns on scaffold were introduced by micro-molding. Microwells were created 
as complementary to the micro-pillar patterns on PDMS replica. The microwells were of 200 
μm in diameter and 50 μm in depth and were created with a 400-μm center-to-center 







Characterization of MSC spheroids on microwell-patterned scaffold 
 
 
Figure 3.4 Characterization of MSC spheroids on microwell patterned scaffolds. (A) 
Spheroids were spatially regulated in microwell arrays. (Blue: DAPI Red: Phalloidin) 
(B) The spherical structure of the MSCs in micro well. (C) MSC spheroids on scaffold 
had upregulated paracrine gene expression. 
Multicellular MSC spheroids were formed after 24 h culture on low-adhesive culture 
plate. The average size of the spheroids is 150 μm in diameter. After being seeded onto 
scaffold, the spheroids were found homogeneously distributed in microwells and maintained 
their spherical structure under fluorescent microscopy (Figure 3.3 A). At the bottom of the 
spheroids, cell spreading on scaffold was observed, indicating the attachment of the 






important factors in angiogenesis and antiapoptosis, in MSC spheroids, MSC spheroids on 
scaffolds and 2-D cultured MSCs. In expression of VEGF, MSC spheroids on scaffolds 
showed a 5.9 fold increase over 2-D cultured MSCs and no significant difference with MSC 
spheroids. In expression of HGF, there is a decrease when spheroids are seeded on scaffolds 
but they still exhibited a markedly 4.6 fold difference over 2-D cultured MSCs (N = 3, n = 3). 
Cell retention of transplanted MSCs in mice model of HLI 
 
 
Scheme 3.1 The design of MSC spheroids loaded microwell-patterned scaffold in mice 
hindlimb ischemia model. 
To investigate in vivo cell retention, MSCs transduced with luciferase were 
transplanted. The intensity of luminescence generated by transduced MSCs positively 
correlates with the number of cells that express luciferase. It was found that spheroids seeded 
on scaffold had a significant 6.7 fold higher luciferase intensity over injection of MSC single 
cells and 6.3 fold higher over injection of MSC spheroids at hours after transplantation. In 
groups where cells were transplanted without scaffold, no signal can be detected after 7 days. 







Evaluation of the in vivo vascularization efficacy of MSC spheroids loaded microwell 
patterned scaffold  
 
Figure 3.5 In vivo optical bioluminescence imaging (BLI) for determination of cell 
retention and survival of MSCs. (A) BLI image representative animals from each 
group at different time point (B) Quantification of BLI signal in regions of interest over 







Figure 3.6 Laser Doppler perfusion imaging (LDPI) images from representative 








Figure 3.7 Representative images from lectin staining of sections from ischemic tissue 
at 7 days and quantification of blood vessels for each group. 
The therapeutic vascularization efficacy was tested in vivo in a mice model of HLI 
(Figure 3.6). Four control groups (no treatment, MSCs single cells, MSC spheroids and 
empty scaffold) were included. LDPI was performed to determine the recovery of blood flow. 






were transplanted. Statistical analysis showed that our strategy had a significant increase of 
blood perfusion over all control groups in the first two weeks (n = 10~15). Immuno-labeling 
of blood vessels was performed to further investigate the functional recovery (Figure 3.7). It 
was found that at 7 days that the blood vessel density was greatly increased over all control 
groups after treatment of MSC spheroids, with a 2.2 fold increase over no treatment group. 
No difference was found among all four control groups (n = 3~4).  
The scaffolds and surrounding tissues were harvested and stained withi H&E. It was 
found that the scaffolds triggered mild foreign body reaction. Blood vessels were found 
around scaffolds as well. 
 
Figure 3.8 H&E staining of implanted scaffold (A) 10x (B) 40x, (*) indicates scaffold 







Therapeutic vascularization is greatly desired in many applications, but the problem 
still remains unsolved. One extensively studied approach for therapeutic vascularization is 
through the delivery of angiogenic growth factors that were found in the natural process of 
vascularization [137]. However, such strategies failed to obtain long lasting benefits, probably 
due to their incapability of recapitulating the natural process where numerous growth factors 
were involved with specified order and concentration gradient, not to mention the difficulties 
in preserving bioactivities of these growth factors. An alternative approach, MSC therapy, 
has potential to overcome these problems. MSCs are able to secrete a broad range of 
therapeutic growth factors. They also have the ability to sense and respond to ischemic 
environment with upregulated angiogenic gene expression. In the form of their multicellular 
3D spheroids, their therapeutic ability is further enhanced. To translate MSC spheroids into 
clinical, nevertheless, the key problem is the design of delivery strategy. In direct injections 
of MSCs, over 90% of cells were lost due to the acute mechanical dispersion. Recently, 
several studies have applied scaffold-based delivery to address this problem. However, little 
focus has been put on the delivery of MSC spheroids, which requires specific design to 
minimize the chance of clumping. 
In this study, a microwell-patterned scaffold was fabricated by combination of 
electrospinning and micromolding. The scaffolds exhibited strong mechanical strength 
comparing with hydrogels. They could maintain integrity in contracting tissues like muscles 
and have no potential of cell loss due to dissociation of scaffolds. Microwells were 






confirmed the scaffolds’ ability in loading MSC spheroids and maintaining the enhanced 
paracrine function.  
Comparing with other patch-based strategies where most scaffolds were several 
millimeters thick and cells were seeded inside, our strategy has two advantages in addition to 
the enhanced paracrine function. First, in our study, cells were seeded only on surface of the 
scaffold that all cells will be closely attached to injured tissue after transplantation, which 
minimizes the distance for nutrient diffusion and also enables potential vascular ingrowth 
and cell integration. The second advantage is the transplantation volume. In our study, the 
application of MSC spheroids and microwell array enables a high cell density with less 
transplantation volume and meanwhile reducing the chance of cell clumping. The reduced 
volume would greatly benefit MSC therapy in human studies.  
Results from BLI demonstrated improved cell retention from our strategy. An early 
cell loss of non-scaffold based delivery was observed, indicating without materials, great 
amount of cells was lost during injection or by the fast wash out after injection and the 
protective effect of the scaffolds against the acute mechanical dispersion.  
Given the transplanted area was well perfused that cells weren’t suffering from 
ischemia, the disappearance of cells after 14 days was likely due to the clearance by immune 
cells, which is a limitation of this strategy and need to be taken into consideration in further 
scaffold design. 
LDPI showed that the vascularization effect of spheroids loaded scaffold is localized, 
which is desired in some cases where off target vascularization is unwanted. It was found 






cells can be seen from BLI and after the disappearance of cells at 14 days, the perfusion also 
started to regress, which might indicate that the perfusion is positively related to cell survival. 
It is also noted that only 2×105 cells were administered in our experiment, which is relatively 
low comparing with most studies where 1 million cells were given, suggesting an increased 
efficiency of our strategy. In this research, the mechanism of the MSC contributed to the 
recovery was not studied that both cell integration and paracrine effect could have possibly 
occurred in this process, which needs to be further investigated. 
The method presented in this study has potential in translation to clinical use. 
Polycarbonate and polyurethane are both approved materials for medical applications. Other 
cell types besides MSC can be applied including genetically engineered cells. It may be 
applied to treat different diseases other than hindlimb ischemia such as myocardial infarction. 
3.5 Conclusion 
In this study, microwell patterned electrospun fibers were fabricated and characterized. 
MSC spheroids loaded microwell-patterned scaffold is an effective MSC transplanting 
strategy with enhanced MSC paracrine function and increased cell retention. This method is 
capable of improve vascularization in ischemic tissues. These findings indicate that the MSC 







CHAPTER 4. DEVELOPMENT OF PORE SIZE CONTROLLABLE 
SCAFFOLDS FOR MESENCHYMAL STEM CELL 
TRANSPLANTATION  
4.1 Introduction 
With the rapid advancement on stem cell and gene technologies, cell based therapy has 
shown great promise in treating diseases which were once considered incurable, such as 
myocardial infarction and diabetes. In most preclinical studies and clinical trials, cells 
suspensions were delivered by direct injection, however, the benefits of cell therapy have 
been limited by the poor survival and rapid removal of cells [138-142]. So far, there is no 
convincing evidence that shows the integration of injected cells with host tissue [143]. 
Therefore, new method for cell delivery with focusing on cell engraftment is demanded. 
Based on these considerations, researchers are now focusing on the scaffold based cell 
therapy [144-148]. Scaffolds can provide physical support for cell attachment and create 
friendly microenvironment of cell growth, as have been describe in the previous chapters of 
this dissertation. 
In applications of scaffold based cell transplantation, cell migration and tissue 
ingrowth after scaffold implantation is a critical process and should be carefully controlled 
[149]. For example, some stem cell types may require migration into host tissue and followed 
by differentiation to perform regeneration [150]; scaffolds with pre-engineered tissue would 
greatly benefit from the ingrowth of blood vessels to prohibit ischemia [151]; in applications 
of transplanting scaffold encapsulated allo-or xenogenic islets, complete restriction of cell 






Pore size is the main character that controls cell migration [153-155]. Studies have shown 
that large open pores can promote cell migration and vascular infiltration while small pores 
(usually less than 1um) can restrict the pass of cells [156-158]. However, in most cases, 
including MSC transplantation, the infiltration of blood vessels and elimination of immune 
cells are both desired [159]. Therefore, the optimization of pore size need to be studied for 
improved cell survival.  
In this study, a hollow spherical scaffold with controllable pore size was developed. 
Cells were injected inside the hollow core, therefore transplanted cells will have no direct 
contact with host tissue. The interaction between host tissue and transplanted cells are solely 
controlled by the pore size of outer membrane. To demonstrate, scaffolds with three different 
pore sizes were fabricated and their morphology, mechanical property and mass transfer 
efficiency were characterized. MSC loaded scaffolds were further transplanted in vivo and 
characterized biocompatibility and cell survival in scaffolds with different pore sizes.  
4.2 Materials and methods 
Materials 
DMAC and Span85 was purchased Sinopharm (Shanghai, China).  PES (Mw 40000) 
was purchased from JUSEP (Changchun, China). PVP (Mw 40000), LiCl, PEG 400 and 
FITC-Dextran (Mw 2,000,000) were purchased from Sigma-Aldrich (Milwaukee, WI, USA). 
The cell culture plates and low-attachment culture plates were from Corning (NY, USA). 
Dulbecco’s phosphate-buffered saline (DPBS) was purchased from Invitrogen (Carlsbad, CA, 






Cyagen (Santa Clara, CA, USA). The suppliers of other chemical and biological reagents are 
specified in the text below. 
Preparation of the pore sized controllable spherical scaffold  
Scaffolds were prepared by a gel–sol phase-inversion method. The polymer solution 
was made by dissolving PES, LiCl, PVP and PEG 400 in DMAC, followed by dropwised 
into a Span85 solution with assist of a syringe pump. Different pore size of scaffolds was 
fabricated by immersing the resulted PES scaffold in DMAC solvent with a predetermined 
time. Then the scaffolds were washed thoroughly with kerosene and rinsed in water for 7 
days to remove trace of organic solvent. The scaffolds were then sterilized with high 
pressure steam and dried for further characterization. 
Microscopic spectroscopic characterization  
To obtain the morphological characteristics of different scaffoldss, different samples 
were gold sputter-coated and examined by the scanning electron microscope (SEM) (S-4800, 
Hitachi, Japan) under acceleration voltage of 15 kV. ImageJ was applied to quantitatively 
characterize the scaffold pore size. For each sample, all pores were selected and measured in 
each image at magnification of 20000x, and a total of 5 images were counted. 
Mechanical analysis 
The mechanical resistance of scaffolds were determined using a texture analyzer (CT3 
4500, Brookfield,USA). The mechanical deformation tests were performed at a mobile probe 







FITC-Dextran (Mw 2,000,000) was dissolved in DPBS to make a final concentration 
of 1 mg/mL. 10 μL of the solution was injected in to each scaffold by microsyringe. 3 
scaffolds were then immersed in 5 mL DPBS in each well of 6 well plate. The plate was 
placed on rotary shaker at speed of 80 rpm in room temperature. 200 μL of solution was 
taken at predetermined time point to read fluorescence under emission wavelength of 490 
nm. 200 μL fresh DPBS was added immediately after the removal of sample solution each 
time after to make a constant total volume of 5 mL. 
Florescent staining of MSCs in scaffold 
        Scaffolds with 3 x 10^5 MSCs were culture for 24 h before embedded in optimal 
cutting temperature compound (Sakura, Alphen aan den Rijn, Nederland). The scaffolds 
were frozen sectioned followed by staining with DAPI and Phalloidin-rhodamine.   
MSC function in scaffolds in vitro 
The total RNA was extracted using the TRIzol kit (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer's instructions, and the RNA concentration determined by 
NanoDrop (Thermo Scientific, Wilmington, DE, USA). 2 μg of the pure total RNA was 
transferred and reverse transcribed with the TransScript First-Strand cDNA Synthesis 
SuperMix (Transgen, Beijing, PR China). The gene expression levels were then analyzed 
using the SYBR Green real-time polymerase chain reaction (PCR) method and quantified 
using the Bio-Rad CFX96 real-time PCR system (Bio-Rad, Hercules, CA, USA). The 
primers were all obtained from Sangon (Shanghai, China). The relative gene expression data 
was analyzed using the 2−ΔΔCT method. All gene expression values were normalized to the β-






In vivo implantation of scaffolds 
All protocols were approved by the Institutional Animal Care and Use Committee of 
Peking University. Male 129 mice (Vital River, Beijing, China), 8-10 weeks’ old were used. 
Scaffolds were loaded with MSCs by injection (3 x 10^5 in 10 μL cell culture medium) one 
day before implantation. Scaffolds were then replaced in 24 well plate with 1 mL complete 
medium for further use. The mice were anaesthetized with anaesthetized with an 
intraperitoneal injection of chloral hydrate (400 mg/kg body weight). The implantation cite 
was shaved and swabbed twice with betadine and DPBS. An incision of 3mm was made near 
groin. A pocket was carefully created by forceps, followed by the insertion of scaffold.  
In vivo tracking of MSC viability 
MSCs were transduced with a lentivirus expressing firefly luciferase, GFP and 
puromycin resistance under the control of the constitutively active cytomegalovirus and 
respiratory syncytial virus promoters, respectively (Hanbio, Shanghai, China). 72 h after 
transduction, MSCs were transferred into standard media containing 1 μg/mL puromycin 
(Solarbio, Beijing, China). Luciferase expression was confirmed with the GFP under 
fluorescence microscope. Animals were introperitoneally injected with luciferin 40 mg/kg 30 
min before imaged using Kodak In-Vivo Imaging Systems (Billerica, MA, USA). 
Luminescence was quantified in the thigh region using Bruker molecular imaging software. 
Histology 
Animals were sacrificed by CO2 inhalation at 15 or 30 days after implantation. Mini-
scaffolds and the surrounding tissues were obtained after fixation in formalin and 






sections were stained with H&E and then imaged by an upright microscope (Olympus DP71, 
Japan). 
4.3 Results and discussion 
 
 
Figure 4.1 Illustration of scaffold preparation 
The scaffold preparation procedure is illustrated in Figure 4.1. The fabrication 
procedure of the scaffold is simple, prolific and highly reproducible. With our experiment 
settings, about 2400 scaffolds can be produced in one hour. The diameter of the scaffold can 
be adjusted by changing the flow rate of polymer solution. The pore size of the scaffold is 
controlled by simply adjusting the immersing time of scaffolds in DMAC. In our study, three 
immersing time, 0 s, 20 s and 40 s were selected to fabricate scaffolds with dense surface, 
nano-pore surface and micro pore surface, respectively.  
Figure 4.2 shows the macro- and micro-view of the scaffolds’ surface morphology and 
inner structure. The scaffold displayed a highly monodispersed macro morphology of hollow 






structure near surface like the classic structure of flat membranes prepared by the well-
known gel–sol phase-inversion method. The samples without immersing in DMAC exhibits 
a dense layer at surface (Figure 4.2 C), with no visible pores under SEM. The dense layer is 
formed by the increase of polymer concentration caused by the initial rapid diffusion of 
DMAC into water. After the formation of dense layer, the solvent exchange decreased and 
porous structures were formed under the surface, as showed in Figure 4.2 B.   
 
Figure 4.2 Representative SEM images of scaffolds. (A-C) dense layer scaffold (D-F) 
nanopore scaffold (G-I) micropore scaffold, scale bar in (A, D and G): 1 mm, (B, E, H 








Figure 4.3 Statistical analysis of pore size distribution. (A) nanopore scaffolds (B) 
micropore scaffolds 
SEM images and the following statistical analysis Figure 4.3 clearly confirmed our 
method of controlling the surface pore size. While no visible pores were found on dense 
layer samples, under SEM the pore size has increased to 0.401±0.187 μm and 9.22 ±3.83 
μm after immersing in DMAC for 20 s and 40 s, respectively. The increase of surface pore 
size is due to the removal of the dense surface layer while immersing in DMAC. When 






pore size of the surface in theory should be controllable from 0 to the pore size of inner 
straight channel which in this case is around 10 μm.  
Mass transfer efficiency is an important character of scaffolds. It determines the 
accessibility of the seeded cell to nutrient and oxygen. Here the mass transfer efficiency of 
three samples with different pore size were compared by testing the release profile of FITC-
Dextran, which is a fluorescent labelled high molecule weight polymer, mimicks the 
diffusion of nutrient. The release curve in Figure 4.4 shows that scaffolds with micropores 
have the fastest release of FITC-Dextran, which reached nearly 100% at 15 hours, while 
scaffolds with nanopores took nearly 72 hours. It is interesting to find that though no pores 
were found on scaffolds with dense layer, there were some release of FITC-Dextran from 
these samples as well. It is possible that the pore size of dense layer scaffolds is too small to 
be observed under SEM. If so, their pore size should be less than 50 nm.  






       The fluorescent staining of MSCs showed that after being loaded cells were attached to 
the inner surface of scaffold (Figure 4.5). The distribution of MSCs on inner surface is 
relatively homogeneous, no obvious cell aggregation was observed.  
 
Figure 4.5 Fluorescent staining of MSCs in scaffolds. (A) nanopore scaffolds, (B) 
micropore scaffolds. (Blue: DAPI, Red: Phalloidin-Rhodamine, bar indicates 500 μm) 
 









Figure 4.7 MSC in vivo survival characterized by bioluminescence (A) representative 
bioluminescence images from scaffolds with different pore size at different time points. 
(B) statistical analysis of MSC survival from bioluminescence test 
Cell function in the three scaffolds were characterized by examine their gene 
expressions. b-FGF, HGF and VEGF are paracrine factor secreted by MSC. They were 
found to have angiogenic, antiapoptosis and antiscarring functions. The gene expression of 






plastic plate being control group. It was found that all three paracrine genes upregulated 
significantly (2-10 times) in all three samples. It was believed that this upregulation may be 
due to the hypoxic environment caused by limited space inside the scaffold. 
 
Figure 4.8 Representative H&E staining of scaffolds and surrounding tissue. Arrows 
indicates blood vessels. 
Finally, the in vivo performance of scaffolds was tested by subcutaneous implantation 
of MSCs loaded scaffold in mice. Dense layer scaffolds were not selected in this experiment 
due to concerns of the limited permeability. The viability of MSCs were track by 
bioluminescence. Figure 4.7 shows the retention transplanted MSCs. It was found that 
directly injected MSCs completely disappeared within 4 days, which is consistent with 
results from others [160]. It is interesting to see that the nanopore scaffold had better cell 
survival over micropore scaffold at all 7 time points, indicating that in our experiment 






survival. It would also be interesting to investigate scaffolds with even smaller pores in 
further work to see how far this trend will go on. There was a huge decrease of MSCs in both 
scaffolds within 24 hours. It was thought that the rapid cell death is due to the hypoxic 
environment before sufficient vascular system is developed around the scaffold. There was 
an increase of MSCs in nanopore scaffold at 4 days. It was assumed this is time point where 
vascularization occurred and cells had enough nutrient to proliferate. Most MSCs in 
scaffolds disappeared 14 days after transplantation.  
HE staining of scaffolds shows that both of the scaffolds triggered mild fibrosis 
(Figure 4.8). Fibrotic tissues of 10 to 50 μm in thickness were found surrounding each 
scaffold. Blood vessels can be found within 100 μm range from surface of all scaffolds. It is 
observed that the blood vessels grew inside nanopore scaffolds at 30 days, which suggests 
that the nano pores are the sufficient to allow ingrowth of vessels so that the final 
disappearance of MSC should not due to insufficient nutrient or oxygen supply but because 
of the clearance of immune cells. Cell can still be found inside scaffolds at 15 and 30 days 
post transplantation. However, with HE staining alone their cell type can hardly be identified. 
They could be MSCs with very low cell number that couldn’t be detected in 
bioluminescence test or they could be infiltrated immune cells.  
Spherical scaffolds have been investigated for cell transplantation. So far, almost all 
spherical scaffolds are based on hydrogels materials such as alginate [161, 162], agarose [163] and 
PEG gels [164]. However, hydrogel beads are mechanically weak and the pore size of 
hydrogels are usually so small that cells can only be loaded at same time with the formation 
of hydrogels. Here, it is the first time that a plastic hollow spherical scaffold with 






several advantages that benefit practical application. First, the PES plastic scaffold shows 
superior mechanical property over hydrogels. They are easy to maneuver. Second, PES is 
known for its stability, which enables the storage and transportation of the premade scaffold.  
Unlike traditional scaffolds, the mini scaffolds have two porous layers and their pore 
sizes can be controlled independently. For the purpose of this study, which is to control 
interaction between host tissues and transplanted cells, the control of pore size of the outer 
membrane was demonstrated. It was shown that the change of out pore size did not affect 
pore size of inner membrane. In addition, in theory the pore size of inner membrane can also 
be regulated by adjusting the formula of polymer solution. It would be an interesting work in 
the future to study scaffold with different inner pore size as well because the inner pore size 
could regulate the microenvironment and distribution of transplanted cells.  
In this study, I demonstrated the mini-scaffold’s application in cell transplantation, 
where they showed ability of improve cell function and controlled cell retention with 
different outer pore size. Meanwhile, this type of scaffold also has potential in a wide range 
of biomedical applications. For example, it can be used for sustained release of drugs. The 
hollow core can be used for drug loading and different pore size can be applied to control 
release rate. There are limitations as well. Firstly, the pore size distribution is relatively 
broad in our technique. The scaffold can serve well as cell delivery vehicle but may not be 
the best candidate for complete immunoisolation applications. Secondly, due to the depth of 








In this study, a pore size controllable hollow spherical scaffold was developed. The 
scaffold has a hollow spherical shape and straight pores in inner surface. The pore size can 
be easily controlled during preparation. In this study, three types of scaffold with different 
pore size were developed. Their structure, secretion profile and mechanical property were 
characterized. It was found that the paracrine gene of MSCs were upregulated after being 
seeded in scaffolds. The MSCs survival in scaffold was evaluated in vivo. It was found that 
MSCs survival can be improved and controlled by different pore size of scaffolds. This 







CHAPTER 5. SUMMARY AND FUTURE DIRECTIONS  
This dissertation focused on the development of scaffolds with integrated properties 
and functions for cell transplantation applications. In this dissertation, three types of novel 
scaffolds with integrated properties were developed and characterized both in vitro and in 
vivo.  
The first scaffold was developed through an integration of hydrophobic polyesters with 
hydrogels. Surface RAFT polymerization technique was adopted to polymerize nanothin 
layer of PEG hydrogels on surface of PCL micro fibers. It is the first time such structure was 
reported. In this way, the composite materials could remain the fibrous and porous nano-
morphology. The introduction of hydrogel is “invisible” from macro view, but after hydrogel 
coating, the material changed from hydrophobic to water absorbable and showed improved 
biocompatibility in vivo. The method developed here is applicable to all polyester scaffolds 
and radical polymerized hydrogels, therefore has wide biomedical applications.   
The second scaffold was developed for transplantation of microtissues. In this work, 
micropatterning was introduced on electrospun fibers so that the scaffolds could not only 
provide ECM like microenvironment, but also gain regulation on a larger scale, the spatial 
distribution of microtissues.  For the first time it was demonstrated that this micropatterned 
scaffold is able to improve cell retention of MSC spheroids after transplantation and achieve 
better tissue vascularization. With the rapid advancement of in vitro microtissue fabrication 
technique, this scaffold will find increasing importance in cell transplantation applications.  
In my third work, a hollow spherical scaffold with controllable pore size developed for 






immune reaction could be optimized. For the first time, MSCs transplanted with the mini-
capsules were demonstrated to improve cell function and retention. The in vivo cell retention 
could be controlled be different pore size of the scaffold surface. It was found that 
vascularization may have greater effect on acute cell survival while immune reactions 
determine the length of cell retention. In the future it would be interesting to fabricate 
scaffolds with smaller pore size to seek optimized cell retention.  
Currently, vascularization is still a major challenge in scaffold based cell 
transplantation. A fast vascularization of the scaffold is strongly preferred to improve early 
survival of the transplanted cells. So far, most of the tissue engineering products are limited 
to tissues such as bones, cartilages and skins where blood vessels are not rich. The sized of 
engineered tissues are also limited by poor vascularization. In our study, I think cell survival 
was greatly hampered by vascularization as well. Therefore, one future focus of my study 
could be the improvements of scaffold vascularization. Studies have shown that one solution 
for improving vascularization is through prevascularization (Figure 5.1). In my case, the 
mini-capsule developed in this dissertation could be implanted alone in advance for 
prevascularization. Then cells could be injected in capsules after the establish of sufficient 







Figure 5.1 Current in situ prevascularization approaches, including angiogenic 
ingrowth (A), flap technique (B) and AV-loop technique (C). A: Implantation of a 
scaffold (gray) into a well-vascularized tissue (orange) induces random ingrowth of 
newly developing microvessels (red). After complete vascularization, the implant is 
transferred to the defect site (blue), where the preformed microvessels develop 
interconnections to the microvessels of the host tissue (green) by inosculation. B: A 
scaffold is implanted into a muscle flap (orange) to allow the random ingrowth of newly 
developing microvessels (red). After prevascularization, the entire flap with the 
incorporated implant is freely transferred to the defect site (blue), where the vascular 
pedicle of the flap is surgically anastomosed to host vessels (green). C: Inside a 
protected growth chamber (dark gray), an AV-loop is incorporated into a scaffold 
(gray) to generate a prevascularized tissue construct by spontaneous sprouting of 
vessels out of the loop (red). The prevascularized tissue construct is then transferred 
and surgically anastomosed to the blood vessels (green) of the defect site (blue) 
(Laschke M W, et al. Biotechnology advances, 2016, 34(2): 112-121.) 
In this dissertation, scaffolds’ applications in cells transplantation were demonstrated 






studied and promising cell types. In fact, these scaffolds with integrated properties also have 
the potential for transplantation of other cell types. For example, islets have a similar size of 
MSC spheroids, which would also prefer spatial regulation during transplantation to avoid 
hypoxia. Therefore, the micropatterned fiber scaffold would greatly benefit the 
transplantation of islets as well.  
However, far more had to be done before cell therapy could finally move from 









Figure A-1 7.5% PEG-PCL reveals the inner PCL core after frozen in liquid nitrogen. 
(A) 4500 x, (B) 13000 x 
 







Figure A-3 BLI image of in vitro cultured MSCs in mini-capsule. Scaffolds loaded with 
6x105, 3 x105, 1.5 x105 and 7.5 x 104 MSCs (from up to bottom, respectively) were 










Figure A-4 In vitro cell survival tested by bioluminescence assay. 
 
Figure A-5 Images of mice with implanted mini-capsules. (A) exterior appearance (B) 







Figure A-6 Anti-inflammatory gene expression of MSCs loaded in scaffolds with 







Figure A-7 Mechanical properties of scaffolds with different pore size from 
compression experiments, (A) force – displacement curve (B) energy spent to compress 
scaffold to 30% strain 
Calculation of proper loading cell number in mini-capsule 
As the mini-capsule has a diameter of 3 mm, it raised concerns of the insufficient 







Figure A-8 The relation between diameter of spherical scaffold and seeding cell density 
(Kim, SK., Yu, SH., Son, JH. et al. Biotechnology Letters (1998) 20: 549.) 
of oxygen consumption, which is proportional to number of cells (Figure A-5). Therefore, 
the maximum cell number was calculated in our capsule in order to avoid hypoxia. The 
equation is listed below: 
ϕ = (rs x rc
2) / (9Ds x So) 
ϕ: Thiele modulus, the ratio of the rate of oxygen consumption and the rate of oxygen 
diffusion, (0.3 is considered well supplied of oxygen and is adopted in this calculation) 
rs: the rate of oxygen consumption of cells = cell density x oxygen consumption of single 
cell (here 98 fmol/cell/h is adopted as median number being reported for MSC oxygen 
consumption [1]) 






Ds: diffusion coefficient of oxygen, as the pores are too big to affect free diffusion of oxygen, 
the coefficient remains the same as oxygen diffusion in water which is 2.5 x 10-5 cm2/s 
So: the solubility of oxygen in water, which is 7 mg/L at room temperature  
Therefore, with all given parameters, the proper cell density is this system is 2.42 x 107 
cells/mL. Given the volume of the scaffold is 14 mm3, the total cell number should be about 
3 x 105. This cell number is further applied in following in vitro and in vivo studies. 
The limitation of this calculation is obvious. This calculation is based on assumptions 
that cells are well – distributed, therefore it is just a rough estimation. Still, it is enough to 
point out the order of magnitude for appropriate cell number.  
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